Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease

INTRODUCTION: An Elecsys® Amyloid β (Aβ [1–42]) immunoassay cutoff for classification of patients with Alzheimer's disease was investigated. METHODS: Cerebrospinal fluid samples collected from patients with mild-to-moderate Alzheimer's disease were analyzed by Elecsys® immunoassays: (1) Aβ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, Leslie M., Waligorska, Teresa, Fields, Leona, Korecka, Magdalena, Figurski, Michal, Trojanowski, John Q., Eichenlaub, Udo, Wahl, Simone, Quan, Marian, Pontecorvo, Michael J., Lachno, D. Richard, Talbot, Jayne A., Andersen, Scott W., Siemers, Eric R., Dean, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222032/
https://www.ncbi.nlm.nih.gov/pubmed/30426066
http://dx.doi.org/10.1016/j.dadm.2018.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222032/
https://www.ncbi.nlm.nih.gov/pubmed/30426066
http://dx.doi.org/10.1016/j.dadm.2018.07.002

Ejemplares similares